2025

ABCSG 61 / TEODOR

ABCSG 61 / TEODOR: First Patient Registered in the Run-in Phase

14.08.2025

The ABCSG is pleased to announce another important milestone in the national phase II study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness). Under the coordination of Dr. Daniel Egle, the first patient was registered in the run-in phase at the Breast Health Center of the Department of Obstetrics and Gynecology at the Medical University of Innsbruck.

read more
ABCSG 61 / TEODOR

ABCSG 61 / TEODOR: First center opened for patient enrollment

30.07.2025

The new ABCSG study ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization driven by ctDNA and endOcrine Responsiveness) has launched with the activation of its first site – the Center for Breast Health in the Department of Gynecology at the Medical University of Vienna, headed by Prof. Christian Singer.

read more
The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials

Congratulations to Dominik Hlauschek on His First Full Publication in ESMO Open!

13.06.2025

A proud moment for the ABCSG statistics team: our colleague Dominik Hlauschek has just published his first full paper in ESMO Open — a key step in his scientific career. Congratulations – and many thanks to Christian Fesl for his leadership and to the whole statistics team for their support!

read more

Share on


Top